Vetticaden Santosh 4
4 · DEPOMED INC · Filed Feb 8, 2018
Insider Transaction Report
Form 4
DEPOMED INCDEPO
Vetticaden Santosh
SVP, Chief Medical Officer ***
Transactions
- Award
Restricted Stock Units
2018-02-06+36,800→ 36,800 total→ Common Stock (36,800 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
- [F2]These restricted stock units are scheduled to vest 33.33% on February 6, 2019, 33.33% on February 6, 2020 and 33.33% on February 6, 2021, assuming continued employment through the applicable vesting date.